SCARPINI, ELIO ANGELO
 Distribuzione geografica
Continente #
EU - Europa 36.277
NA - Nord America 32.804
AS - Asia 31.278
SA - Sud America 3.014
AF - Africa 689
OC - Oceania 294
Continente sconosciuto - Info sul continente non disponibili 36
Totale 104.392
Nazione #
US - Stati Uniti d'America 31.424
GB - Regno Unito 11.278
CN - Cina 9.611
SG - Singapore 9.375
IT - Italia 6.068
DE - Germania 4.381
SE - Svezia 3.095
RU - Federazione Russa 2.936
VN - Vietnam 2.500
HK - Hong Kong 2.460
BR - Brasile 2.143
FR - Francia 1.825
IN - India 1.793
UA - Ucraina 1.315
BD - Bangladesh 1.225
TR - Turchia 1.191
NL - Olanda 1.181
IE - Irlanda 1.127
CA - Canada 1.041
KR - Corea 1.035
FI - Finlandia 796
JP - Giappone 491
EU - Europa 482
PL - Polonia 447
ID - Indonesia 400
CO - Colombia 388
ES - Italia 359
DK - Danimarca 276
GR - Grecia 265
AU - Australia 259
CI - Costa d'Avorio 235
BE - Belgio 213
IR - Iran 192
AR - Argentina 178
MX - Messico 163
AT - Austria 141
CH - Svizzera 131
IQ - Iraq 131
ZA - Sudafrica 114
PK - Pakistan 92
TW - Taiwan 80
UZ - Uzbekistan 79
RO - Romania 71
MA - Marocco 70
EC - Ecuador 69
PH - Filippine 68
PT - Portogallo 68
VE - Venezuela 67
IL - Israele 64
JO - Giordania 64
SA - Arabia Saudita 61
CL - Cile 60
MY - Malesia 56
CZ - Repubblica Ceca 49
EG - Egitto 48
AE - Emirati Arabi Uniti 43
TN - Tunisia 43
NO - Norvegia 42
PE - Perù 41
KE - Kenya 38
NZ - Nuova Zelanda 33
DZ - Algeria 28
PY - Paraguay 28
TH - Thailandia 28
NP - Nepal 27
JM - Giamaica 26
UY - Uruguay 26
AZ - Azerbaigian 22
LT - Lituania 21
LU - Lussemburgo 21
KZ - Kazakistan 20
RS - Serbia 20
CR - Costa Rica 19
HU - Ungheria 19
BG - Bulgaria 18
CY - Cipro 17
LB - Libano 17
GT - Guatemala 16
HN - Honduras 16
LV - Lettonia 16
PA - Panama 16
SN - Senegal 15
TT - Trinidad e Tobago 15
DO - Repubblica Dominicana 14
ET - Etiopia 14
QA - Qatar 14
KH - Cambogia 13
OM - Oman 13
HR - Croazia 12
AL - Albania 11
BO - Bolivia 11
AM - Armenia 10
BY - Bielorussia 10
EE - Estonia 10
KG - Kirghizistan 10
NG - Nigeria 10
PS - Palestinian Territory 10
XK - ???statistics.table.value.countryCode.XK??? 10
GA - Gabon 9
IS - Islanda 9
Totale 104.612
Città #
Southend 9.870
Singapore 5.532
Ashburn 2.903
Hong Kong 2.253
Chandler 2.122
Milan 1.836
San Jose 1.810
Beijing 1.711
Seattle 1.711
Princeton 1.311
Wilmington 1.121
Dublin 1.082
Frankfurt am Main 1.038
Council Bluffs 1.023
Jacksonville 984
Fairfield 882
Dallas 815
New York 804
Ann Arbor 763
Santa Clara 749
Ho Chi Minh City 741
Los Angeles 712
Bengaluru 678
Woodbridge 665
Nanjing 651
Hanoi 618
Houston 605
Lauterbourg 568
Redmond 564
Cambridge 511
Hefei 495
Toronto 482
Des Moines 443
Dearborn 438
Buffalo 427
Mountain View 422
Guangzhou 414
Boardman 409
Shanghai 405
Somerville 388
Moscow 381
Serra 376
Berlin 373
Warsaw 355
Sakarya 348
Redwood City 341
Bogotá 331
Andover 326
Tokyo 294
The Dalles 279
Jinan 276
Ottawa 247
Jakarta 245
Helsinki 242
Shenyang 240
Hangzhou 236
Abidjan 234
Athens 209
Phoenix 209
Rome 209
Cangzhou 205
Columbus 205
Tianjin 205
Kent 204
São Paulo 200
Nanchang 187
Munich 185
Changsha 156
Nuremberg 148
London 145
Hebei 136
Brussels 132
Istanbul 129
Seoul 128
Zhengzhou 122
Da Nang 117
Turin 117
Chicago 116
Fuzhou 113
Haiphong 109
Norwalk 103
Shenzhen 98
San Diego 95
Naples 94
Jiaxing 90
Amsterdam 86
Medford 84
Hanover 78
Atlanta 76
Dong Ket 71
Wuhan 71
Bühl 70
Washington 70
Bitonto 69
San Francisco 69
Grafing 67
Lowell 67
Chengdu 66
Odernheim 65
Rio de Janeiro 65
Totale 61.320
Nome #
Transcranial direct current stimulation (tDCS) for fatigue in multiple sclerosis 1.260
Mapping the human genetic architecture of COVID-19 1.112
Trial of solanezumab for mild dementia due to Alzheimer's disease 716
Exploring the role of BDNF DNA methylation and hydroxymethylation in patients with obsessive compulsive disorder 573
Balò’s concentric sclerosis : still to be considered as a variant of multiple sclerosis? 529
CSF β-amyloid predicts prognosis in patients with multiple sclerosis 513
Alemtuzumab in multiple sclerosis during the COVID-19 pandemic: A mild uncomplicated infection despite intense immunosuppression 469
Epigenetic modulation of BDNF gene in patients with major depressive disorder 464
Heterozygous TREM2 mutations in frontotemporal dementia 419
Detailed stratified GWAS analysis for severe COVID-19 in four European populations 401
Phenotypic variability associated with the C9ORF72 hexanucleotide repeat expansion : a sporadic case of frontotemporal lobar degeneration with prodromal hyposmia and predominant semantic deficits 401
New insights into the genetic etiology of Alzheimer's disease and related dementias 400
"Delirium Day" : A nationwide point prevalence study of delirium in older hospitalized patients using an easy standardized diagnostic tool 392
Age at symptom onset and death and disease duration in genetic frontotemporal dementia : an international retrospective cohort study 383
Alzheimer's Disease Diagnosis: Discrepancy between Clinical, Neuroimaging, and Cerebrospinal Fluid Biomarkers Criteria in an Italian Cohort of Geriatric Outpatients: A Retrospective Cross-sectional Study 363
Psychiatric Disorders in Alzheimer Disease With the Presenilin-1 L226F Mutation 350
Clinical features and disease course of patients with acute ischaemic stroke just before the Italian index case: Was COVID-19 already there? 346
Recognition of viral and self-antigens by TH1 and TH1/TH17 central memory cells in patients with multiple sclerosis reveals distinct roles in immune surveillance and relapses 339
Gene-wide analysis detects two new susceptibility genes for Alzheimer's disease 336
The novel GRN g.1159-1160delTG mutation is associated with behavioral variant frontotemporal dementia 330
A functional variant in ERAP1 predisposes to multiple sclerosis 329
Uncovering the heterogeneity and temporal complexity of neurodegenerative diseases with Subtype and Stage Inference 326
Influence of the Glu298Asp polymorphism of NOS3 on age at aonset and homocysteine levels in AD patients 324
Frontotemporal dementia and its subtypes: a genome-wide association study 321
Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing 309
Transcranial direct current stimulation improves recognition memory in Alzheimer disease 305
Rs5848 Variant Influences GRN mRNA Levels in Brain and Peripheral Mononuclear Cells in Patients with Alzheimer’s Disease 304
The results of two multicenter, open-label studies assessing efficacy, tolerability and safety of protiramer, a high molecular weight synthetic copolymeric mixture, in patients with relapsing-remitting multiple sclerosis 302
NOS3 Glu298Asp polymorphism is a risk factor for frontotemporal lobar degeneration 295
Progranulin gene variability and plasma levels in bipolar disorder and schizophrenia 292
Weight loss predicts progression of mild cognitive impairment to Alzheimer's disease 291
Usefulness of multi-parametric MRI for the investigation of posterior cortical atrophy 289
Vascular risk factors do not individually effect risk of conversion of mild cognitive impairment to dementia. 286
The T-786C NOS3 polymorphism in Alzheimer's disease : association and influence on gene expression 283
Evidence of pre-synaptic dopaminergic deficit in a patient with a novel progranulin mutation presenting with atypical parkinsonism 283
Role of hnRNP-A1 and miR-590-3p in neuronal death : genetics and expression analysis in patients with Alzheimer’s disease and frontotemporal lobar degeneration 282
The Enigmatic Role of Viruses in Multiple Sclerosis : Molecular Mimicry or Disturbed Immune Surveillance? 276
Distinct patterns of brain atrophy in Genetic Frontotemporal Dementia Initiative (GENFI) cohort revealed by visual rating scales 276
Screening of the PFN1 gene in sporadic amyotrophic lateral sclerosis and in frontotemporal dementia 272
Progranulin gene mutation scanning in Alzheimer's disease and frontotemporal lobar degeneration: functional and phenotypic correlations. 270
Gender effects on plasma PGRN levels in patients with Alzheimer's disease : a preliminary study 267
P-selectin glycoprotein ligand-1 variable number of tandem repeats (VNTR) polymorphism in patients with multiple sclerosis 265
Changes in vitamin B12 and tumour necrosis factor-a levels in cerebrospinal fluid of patients with different subtypes of multiple sclerosis 264
The loss of macular ganglion cells begins from the early stages of disease and correlates with brain atrophy in multiple sclerosis patients 263
CSF β-amyloid predicts early cerebellar atrophy and is associated with a poor prognosis in multiple sclerosis 262
Parieto-occipital sulcus widening differentiates posterior cortical atrophy from typical Alzheimer disease 262
Prolonged Visual Memory Enhancement After Direct Current Stimulation In Alzheimer Disease 261
DCUN1D1 is a risk factor for frontotemporal lobar degeneration 257
Transcranial direct current stimulation modulates cortical neuronal activity in Alzheimer's disease 257
+10 T/C polymorphisms in the gene of transforming growth factor-β1 are associated with neurodegeneration and its clinical evolution 256
MiRNA Profiling in Plasma Neural-Derived Small Extracellular Vesicles from Patients with Alzheimer's Disease 256
Cerebrospinal fluid glutamate changes in functional movement disorders 256
Causal frontotemporal de generation mutations : a novel MAPT mutation associated with the clinical phenotype of progressive nonfluent aphasia 255
Genome-wide haplotype association study identifies the FRMD4A gene as a risk locus for Alzheimer's disease 255
Gene promoter methylation and expression of Pin1 differ between patients with frontotemporal dementia and Alzheimer's disease 254
Total homocysteine levels in AD patients : analysis on different onset subgroups 253
Epigenetic regulation of fatty acid amide hydrolase in Alzheimer disease 253
E-selectin A561C and G98T polymorphisms influence susceptibility and course of multiple sclerosis 252
Incomplete penetrance of the C9ORF72 hexanucleotide repeat expansions : Frequency in a cohort of geriatric non-demented subjects 252
Pin1 contribution to Alzheimer's disease : transcriptional and epigenetic mechanisms in patients with late-onset Alzheimer's disease 251
Behavioral and Neurophysiological Effects of Transcranial Direct Current Stimulation (tDCS) in Fronto-Temporal Dementia 251
A novel polymorphism in SEL1L confers susceptibility to Alzheimer's disease 250
Late-onset presentation and phenotypic heterogeneity of the rare R377W PSEN1 mutation 250
Progranulin plasma levels as potential biomarker for the identification of GRN deletion carriers. A case with atypical onset as clinical amnestic Mild Cognitive Impairment converted to Alzheimer's disease 249
Progress in Alzheimer's disease research in the last year 249
Novel exon 1 progranulin gene variations in Alzheimer's disease and frontotemporal lobar degeneration 248
Progranulin gene variability increases the risk for primary progressive multiple sclerosis in males 248
Exosome determinants of physiological aging and age-related neurodegenerative diseases 248
Genetic and functional analysis of progranulin gene variants in Alzheimer's disease. 247
GRN variability contributes to sporadic frontotemporal lobar degeneration 247
Repetitive element hypermethylation in multiple sclerosis patients 247
Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores 246
BAG1 is a protective factor for sporadic frontotemporal lobar degeneration but not for Alzheimer's disease 245
DNA methylation in repetitive elements and Alzheimer disease 244
IL-33 and its decoy sST2 in patients with Alzheimer's disease and mild cognitive impairment 243
Novel exon 1 progranulin gene variant in Alzheimer’s disease 242
P-selectin glycoprotein ligand-1 variable number of tandem repeats (VNTR) polymorphism in patients with multiple sclerosis 241
Clinical value of cerebrospinal fluid neurofilament light chain in semantic dementia 241
Functional network resilience to pathology in presymptomatic genetic frontotemporal dementia 240
Diogenes syndrome in dementia: a case report 240
Cerebrospinal fluid progranulin levels in patients with different multiple sclerosis subtypes 239
The leukocyte expression of CD36 is low in patients with Alzheimer's disease and mild cognitive impairment 235
Candidate gene analysis of semaphorins in patients with Alzheimer's disease 235
Validation of the Italian Addenbrooke’s cognitive examination revised (ACE-R) as a screening test 235
Secondary prevention of cryptogenic stroke in patients with patent foramen ovale : a systematic review and meta-analysis 232
Loss of cobalamin-mediated regulation leads to decreased EGF and increased soluble CD40 levels in cerebrospinal fluid of patients with multiple sclerosis 230
Testing the 2018 NIA-AA research framework in a retrospective large cohort of patients with cognitive impairment: From biological biomarkers to clinical syndromes 230
Association between VEGF gene and sporadic Alzheimer's disease. 228
Role of OLR1 and its regulating hsa-miR369-3p in Alzheimer’s disease : genetics and expression analysis 228
Plasma ghrelin concentrations in elderly subjects: comparison with anorexic and obese patients 227
Transcranial Direct Current Stimulation (tDCS) for Fatigue in Multiple Sclerosis 226
Profiling of ubiquitination pathway genes in peripheral cells from patients with frontotemporal dementia due to C9ORF72 and GRN mutations 226
Absence of mutations in TREM-2 coding region in early onset dementia 225
Safety of MF59-adjuvanted influenza vaccination in the elderly: results of a comparative study of MF59-adjuvanted vaccine versus nonadjuvanted influenza vaccine in Northern Italy 224
Alterazioni proteine tau liquorali e quoziente intellettivo (QI) nelle Distrofie Miotonichew di tipo 1 (DM1) e di tipo 2 (DM2). 223
Transcranial direct current stimulation (tDCS) improves cognitive function in Alzheimer patients 223
Progranulin gene mutation scanning in Alzheimer's disease and Frontotemporal Lobar Degeneration: fuctional and phenotypic correlations 223
Progranulin gene mutation scanning and expression analysis in patients with Alzheimer's disease 222
Brain polarization (tDCS) improves recognition memory in patients with probable Alzheimer disease. 221
Intrathecal chemokine synthesis in mild cognitive impairment and Alzheimer disease 220
Totale 30.630
Categoria #
all - tutte 312.311
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 312.311


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.313 0 0 0 0 0 0 0 0 0 0 1.590 723
2021/20226.743 527 295 231 337 497 371 655 374 864 676 493 1.423
2022/20238.936 1.182 844 705 938 1.071 1.730 247 549 918 169 405 178
2023/20246.392 228 483 360 367 1.682 417 373 358 222 449 638 815
2024/202514.526 543 1.470 311 1.416 1.214 568 565 1.563 827 1.398 1.329 3.322
2025/202630.093 2.975 1.812 2.819 2.414 2.810 2.091 3.851 2.018 3.790 2.415 3.098 0
Totale 109.471